Advertisement

A Purified Saponin Acts as an Adjuvant for a T-Independent Antigen

  • A. C. White
  • P. Cloutier
  • R. T. Coughlin
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 303)

Abstract

Three strains of mice were injected with a T-independent antigen, Escherichia coli 055:B5 polysaccharide (PS) combined with purified saponin, QS-21, isolated from Quillaia saponaria bark. PS was prepared by hydrolysis of lipopolysaccharide (LPS). Nine week old mice were injected intradermally with 60 ug PS, as determined by an anthrone assay, with or without 15 ug QS-21 on days 0 and 14. On day 22 sera were assayed by EIA for PS specific antibodies. Titers were 11-fold higher in CD-1 mice with QS-21. C3H/HeJ (lpsd) and C3H/HeSnJ (lpsr) mice also showed an adjuvant associated increase in titer with saponin. Therefore, LPS responsiveness was not required for the adjuvant effect. PS vaccinated C3H and CD-1 mice with and without QS-21 had similar antibody isotype profiles. lgG2b titers accounted for more than half of the total Ig response. lgG2a was next highest followed by lgG3, IgM, lgG1, and IgA. In comparison, CD-1 mice injected with 0.1 ug intact LPS had a different LPS specific isotype profile. lgG3 was the highest followed by lgG1, lgG2b, IgM, lgG2a, and IgA.

Keywords

Adjuvant Effect Mouse Seron Water Emulsion Isotype Profile Immune Mouse Seron 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chaplin, M. F., 1986, Monosaccharides, in: “Carbohydrate Analysis, A Practical Approach,” M. F. Chaplin and J. F. Kennedy, eds., IRL Press, Oxford.Google Scholar
  2. Coughlin, R. T. and Bogard, W. C. (1987) Immunoprotective murine monoclonal antibodies specific for the outer-core polysaccharide and for the O-antigen of Escherichia coli 0111:B4 lipopolysaccharide (LPS), J. Immunol. 139:557.PubMedGoogle Scholar
  3. Cryz, S., Sadoff, J., and Furer, E. (1988) Immunization with a Pseudomonas aeruginosa immunotype 5 O polysaccharide-Toxin A conjugate vaccine: Effect of a booster dose on antibody levels in humans, Infect. Immun. 56:1829.PubMedGoogle Scholar
  4. Kensil, C., Patel, U., Lennick, M., and Marciani, D. J. (in press: J. Immunol) Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina.Google Scholar
  5. Rudbach, J. A., Cantrell, J. L, Ulrich, J. T., and Mitchell, M. S., 1990, Immunotherapy with bacterial endotoxins, in: “Endotoxin,” H. Friedman, T.W. Klein, M. Nakano, and A. Nowotny, eds., Plenum Press, New York.Google Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • A. C. White
    • 1
  • P. Cloutier
    • 1
  • R. T. Coughlin
    • 1
  1. 1.Cambridge Biotech CorporationWorcesterUSA

Personalised recommendations